The peptide also demonstrates remarkable cytoprotective effects across multiple tissue types
A prescription written today and never followed up is not consistent with the standard of care, particularly at higher doses
This is not the same as FDA-approved use, but it may allow eligible patients to begin their weight loss journey today
PlexusDx annualized pricing at month-to-month rates: Microdose GLP-1 Protocol $1,548/year ($129/mo flat), Semaglutide Injection $2,268/year ($189/mo, or $1,788/year at $149/mo on the 6-month plan), Tirzepatide Injection $3,468/year ($289/mo, or $2,988/year at $249/mo on the 6-month plan), GLP-Squared $3,468/year ($289/mo)
An overwhelming body of clinical evidence shows that semaglutide is superior to liraglutide (a weight loss medication) in reducing body weight and blood sugar levels: Tirzepatide and semaglutide are both GLP-1 receptor agonists, which means they work by binding to the GLP-1 receptor in the gut to help control blood sugar levels